(Q31885850)

4 July 2017

Leflunomide inhibits activation of inducible nitric oxide synthase in rat astrocytes (English)

1 reference

Stanislava Stosic-Grujicic

4 July 2017

0 references

D Popadic

5

0 references

object named as

S Stosic-Grujicic

4

0 references

author name string

D Miljkovic

1

1 reference

4 July 2017

T Samardzic

2

1 reference

4 July 2017

M Mostarica Stojkovic

3

1 reference

4 July 2017

V Trajkovic

6

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

889

1 reference

4 July 2017

331-338

1 reference

4 July 2017

1-2

1 reference

Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis.

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

The NF-kappa B and I kappa B proteins: new discoveries and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Endogenous nitric oxide in cardiovascular disease and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Nitric oxide: a cytotoxic activated macrophage effector molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Cell-Specific Inhibition of Inducible Nitric Oxide Synthase Activation by Leflunomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Possible involvement of Janus kinase Jak2 in interferon-gamma induction of nitric oxide synthase in rat glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Regulation of lymphocyte functions by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Nitric oxide and macrophage function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Strategies of protection from nitric oxide toxicity in islet inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Nerve conduction block by nitric oxide that is mediated by the axonal environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903181-4

10.1016/S0006-8993(00)03181-4

7 January 2021

Identifiers

DOI

1 reference

4 July 2017

1 reference